Global Veterinary Diagnostics Market 2014-2018
出 版 商：Infiniti Research
出版日期：2014/08/13
頁 數：96頁
文件格式：PDF
價 格：
USD 2,500 (Single-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
USD 2,800 (Multi-User License)
USD 3,500 (Global-User License)
About Veterinary Diagnostics
Veterinary diagnostics include various tests, which are used to detect diseases in animals. Veterinarians, pet owners, livestock producers, and biomedical researchers are mainly availing these diagnostic services. Major diagnostic methods include molecular testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, and hematology. These tests are executed through blood, urine, tissue, and feces samples from animals.
TechNavio's analysts forecast the Global Veterinary Diagnostics market to grow at a CAGR of 8.10 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Veterinary Diagnostics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following five segments:
‧ Clinical Chemistry
‧ Hematology Analyzers
‧ Molecular Diagnostics
‧ Immunodiagnostics
‧ Diagnostics Imaging
TechNavio's report, the Global Veterinary Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Veterinary Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abaxis
‧ Heska
‧ IDEXX Laboratories
‧ Mindray Medical
‧ VCA Antech
‧ Zoetis
Other Prominent Vendors
‧ Neogen
‧ Thermo Fisher Scientific
‧ Virbac
Market Driver
‧ Increased Prevalence of Diseases in Animals
‧ For a full, detailed list, view our report
Market Challenge
‧ Low Animal Healthcare Expenditure
‧ For a full, detailed list, view our report
Market Trend
‧ Early Animal Molecular Diagnostics
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
Veterinary diagnostics include various tests, which are used to detect diseases in animals. Veterinarians, pet owners, livestock producers, and biomedical researchers are mainly availing these diagnostic services. Major diagnostic methods include molecular testing (Deoxyribonucleic Acid/Ribonucleic Acid testing), immunodiagnostics, clinical chemistry, and hematology. These tests are executed through blood, urine, tissue, and feces samples from animals.
TechNavio's analysts forecast the Global Veterinary Diagnostics market to grow at a CAGR of 8.10 percent over the period 2013-2018.
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Veterinary Diagnostics market for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following five segments:
‧ Clinical Chemistry
‧ Hematology Analyzers
‧ Molecular Diagnostics
‧ Immunodiagnostics
‧ Diagnostics Imaging
TechNavio's report, the Global Veterinary Diagnostics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Veterinary Diagnostics market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key Regions
‧ Americas
‧ APAC
‧ EMEA
Key Vendors
‧ Abaxis
‧ Heska
‧ IDEXX Laboratories
‧ Mindray Medical
‧ VCA Antech
‧ Zoetis
Other Prominent Vendors
‧ Neogen
‧ Thermo Fisher Scientific
‧ Virbac
Market Driver
‧ Increased Prevalence of Diseases in Animals
‧ For a full, detailed list, view our report
Market Challenge
‧ Low Animal Healthcare Expenditure
‧ For a full, detailed list, view our report
Market Trend
‧ Early Animal Molecular Diagnostics
‧ For a full, detailed list, view our report
Key Questions Answered in this Report
‧ What will the market size be in 2018 and what will the growth rate be?
‧ What are the key market trends?
‧ What is driving this market?
‧ What are the challenges to market growth?
‧ Who are the key vendors in this market space?
‧ What are the market opportunities and threats faced by the key vendors?
‧ What are the strengths and weaknesses of the key vendors?
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
08. Global Clinical Chemistry market 2013-2018
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Immunodiagnostics market 2013-2018
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Hematology market 2013-2018
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Molecular Diagnostics market 2013-2018
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Diagnostics Imaging market 2013-2018
12.1 Market Overview
12.2 Market Size and Forecast
13. Market Segmentation by type of Animal
14. Geographical Segmentation
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2013
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 Abaxis
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation by Revenue 2013
23.1.4 Business Segmentation by Revenue 2013 and 2014
23.1.5 Geographical Segmentation by Revenue 2013
23.1.6 Business Strategy
23.1.7 Recent Developments
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 IDEXX Laboratories
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Geographical Segmentation by Revenue 2013
23.2.6 Business Strategy
23.2.7 Recent Developments
23.2.8 SWOT Analysis
23.2.9 Strengths
23.2.10 Weaknesses
23.2.11 Opportunities
23.2.12 Threats
23.3 Heska
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Business Segmentation
23.3.4 Business Segmentation by Revenue 2012 and 2013
23.3.5 Geographical Segmentation by Revenue 2013
23.3.6 Business Strategy
23.3.7 Recent Developments
23.3.8 SWOT Analysis
23.3.9 Strengths
23.3.10 Weaknesses
23.3.11 Opportunities
23.3.12 Threats
23.4 VCA
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue 2013
23.4.6 Business Strategy
23.4.7 Recent Developments
23.4.8 SWOT Analysis
23.4.9 Strengths
23.4.10 Weaknesses
23.4.11 Opportunities
23.4.12 Threats
23.5 Mindray Medical International
23.5.1 Key Facts
23.5.2 Business Overview
23.5.3 Business Segmentation by Revenue 2013
23.5.4 Business Segmentation by Revenue 2012 and 2013
23.5.5 Geographical Segmentation by Revenue 2013
23.5.6 Business Strategy
23.5.7 Recent Developments
23.5.8 SWOT Analysis
23.5.9 Strengths
23.5.10 Weaknesses
23.5.11 Opportunities
23.5.12 Threats
23.6 Zoetis
23.6.1 Key Facts
23.6.2 Business Overview
23.6.3 Business Segmentation by Revenue 2013
23.6.4 Business Segmentation by Revenue 2012 and 2013
23.6.5 Geographical Segmentation by Revenue 2013
23.6.6 Business Strategy
23.6.7 Recent Developments
23.6.8 SWOT Analysis
23.6.9 Strengths
23.6.10 Weaknesses
23.6.11 Opportunities
23.6.12 Threats
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Veterinary Diagnostics Market 2013-2018 in (US$ million)
Exhibit 3: Global Veterinary Diagnostics Market by Product Segmentation
Exhibit 4: Global Veterinary Diagnostic Market Segmentation by type of Tests 2013-2018 in (US$ million)
Exhibit 5: Global Veterinary Diagnostic Market Segmentation by type of Tests 2013-2018
Exhibit 6: Global Clinical Chemistry Market 2013-2018 (US$ million )
Exhibit 7: Global Immunodiagnostics Market 2013-2018 (US$ million)
Exhibit 8: Global Hematology Market 2013-2018 (US$ million)
Exhibit 9: Global Molecular Diagnostics Market 2013-2018 (US$ million)
Exhibit 10: Global Diagnostics Imaging Market 2013-2018 (US$ million)
Exhibit 11: Global Veterinary Diagnostics Market by type of Animal
Exhibit 12: Global market segment by Animal type
Exhibit 13: Global Veterinary Diagnostics market by geographical segmentation
Exhibit 14: Global Veterinary Diagnostics market share segmentation of major key vendors
Exhibit 15: Abaxis: Business Segmentation by Revenue 2013
Exhibit 16: Abaxis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 17: Abaxis: Geographical Segmentation by Revenue 2013
Exhibit 18: IDEXX Laboratories: Business Segmentation by Revenue 2013
Exhibit 19: IDEXX Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 20: IDEXX Laboratories: Geographical Segmentation by Revenue 2013
Exhibit 21: Heska: Business Segmentation 2013
Exhibit 22: Heska: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 23: Heska: Geographical Segmentation by Revenue 2013
Exhibit 24: VCA: Business Segmentation by Revenue 2013
Exhibit 25: VCA: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 26: VCA: Geographical Segmentation by Revenue 2013
Exhibit 27: Mindray Medical International: Business Segmentation by Revenue 2013
Exhibit 28: Mindray Medical International: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: Mindray Medical International: Geographical Segmentation by Revenue 2013
Exhibit 30: Zoetis: Business Segmentation by Revenue 2013
Exhibit 31: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: Zoetis: Geographical Segmentation by Revenue 2013
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis
07. Market Segmentation by Product
08. Global Clinical Chemistry market 2013-2018
08.1 Market Overview
08.2 Market Size and Forecast
09. Global Immunodiagnostics market 2013-2018
09.1 Market Overview
09.2 Market Size and Forecast
10. Global Hematology market 2013-2018
10.1 Market Overview
10.2 Market Size and Forecast
11. Global Molecular Diagnostics market 2013-2018
11.1 Market Overview
11.2 Market Size and Forecast
12. Global Diagnostics Imaging market 2013-2018
12.1 Market Overview
12.2 Market Size and Forecast
13. Market Segmentation by type of Animal
14. Geographical Segmentation
15. Buying Criteria
16. Market Growth Drivers
17. Drivers and their Impact
18. Market Challenges
19. Impact of Drivers and Challenges
20. Market Trends
21. Trends and their Impact
22. Vendor Landscape
22.1 Competitive Scenario
22.1.1.1 Key News
22.1.2 Mergers and Acquisitions
22.2 Market Share Analysis 2013
22.3 Other Prominent Vendors
23. Key Vendor Analysis
23.1 Abaxis
23.1.1 Key Facts
23.1.2 Business Overview
23.1.3 Business Segmentation by Revenue 2013
23.1.4 Business Segmentation by Revenue 2013 and 2014
23.1.5 Geographical Segmentation by Revenue 2013
23.1.6 Business Strategy
23.1.7 Recent Developments
23.1.8 SWOT Analysis
23.1.9 Strengths
23.1.10 Weaknesses
23.1.11 Opportunities
23.1.12 Threats
23.2 IDEXX Laboratories
23.2.1 Key Facts
23.2.2 Business Overview
23.2.3 Business Segmentation by Revenue 2013
23.2.4 Business Segmentation by Revenue 2012 and 2013
23.2.5 Geographical Segmentation by Revenue 2013
23.2.6 Business Strategy
23.2.7 Recent Developments
23.2.8 SWOT Analysis
23.2.9 Strengths
23.2.10 Weaknesses
23.2.11 Opportunities
23.2.12 Threats
23.3 Heska
23.3.1 Key Facts
23.3.2 Business Overview
23.3.3 Business Segmentation
23.3.4 Business Segmentation by Revenue 2012 and 2013
23.3.5 Geographical Segmentation by Revenue 2013
23.3.6 Business Strategy
23.3.7 Recent Developments
23.3.8 SWOT Analysis
23.3.9 Strengths
23.3.10 Weaknesses
23.3.11 Opportunities
23.3.12 Threats
23.4 VCA
23.4.1 Key Facts
23.4.2 Business Overview
23.4.3 Business Segmentation by Revenue 2013
23.4.4 Business Segmentation by Revenue 2012 and 2013
23.4.5 Geographical Segmentation by Revenue 2013
23.4.6 Business Strategy
23.4.7 Recent Developments
23.4.8 SWOT Analysis
23.4.9 Strengths
23.4.10 Weaknesses
23.4.11 Opportunities
23.4.12 Threats
23.5 Mindray Medical International
23.5.1 Key Facts
23.5.2 Business Overview
23.5.3 Business Segmentation by Revenue 2013
23.5.4 Business Segmentation by Revenue 2012 and 2013
23.5.5 Geographical Segmentation by Revenue 2013
23.5.6 Business Strategy
23.5.7 Recent Developments
23.5.8 SWOT Analysis
23.5.9 Strengths
23.5.10 Weaknesses
23.5.11 Opportunities
23.5.12 Threats
23.6 Zoetis
23.6.1 Key Facts
23.6.2 Business Overview
23.6.3 Business Segmentation by Revenue 2013
23.6.4 Business Segmentation by Revenue 2012 and 2013
23.6.5 Geographical Segmentation by Revenue 2013
23.6.6 Business Strategy
23.6.7 Recent Developments
23.6.8 SWOT Analysis
23.6.9 Strengths
23.6.10 Weaknesses
23.6.11 Opportunities
23.6.12 Threats
List of Exhibits
Exhibit 1: Market Research Methodology
Exhibit 2: Global Veterinary Diagnostics Market 2013-2018 in (US$ million)
Exhibit 3: Global Veterinary Diagnostics Market by Product Segmentation
Exhibit 4: Global Veterinary Diagnostic Market Segmentation by type of Tests 2013-2018 in (US$ million)
Exhibit 5: Global Veterinary Diagnostic Market Segmentation by type of Tests 2013-2018
Exhibit 6: Global Clinical Chemistry Market 2013-2018 (US$ million )
Exhibit 7: Global Immunodiagnostics Market 2013-2018 (US$ million)
Exhibit 8: Global Hematology Market 2013-2018 (US$ million)
Exhibit 9: Global Molecular Diagnostics Market 2013-2018 (US$ million)
Exhibit 10: Global Diagnostics Imaging Market 2013-2018 (US$ million)
Exhibit 11: Global Veterinary Diagnostics Market by type of Animal
Exhibit 12: Global market segment by Animal type
Exhibit 13: Global Veterinary Diagnostics market by geographical segmentation
Exhibit 14: Global Veterinary Diagnostics market share segmentation of major key vendors
Exhibit 15: Abaxis: Business Segmentation by Revenue 2013
Exhibit 16: Abaxis: Business Segmentation by Revenue 2013 and 2014 (US$ million)
Exhibit 17: Abaxis: Geographical Segmentation by Revenue 2013
Exhibit 18: IDEXX Laboratories: Business Segmentation by Revenue 2013
Exhibit 19: IDEXX Laboratories: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 20: IDEXX Laboratories: Geographical Segmentation by Revenue 2013
Exhibit 21: Heska: Business Segmentation 2013
Exhibit 22: Heska: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 23: Heska: Geographical Segmentation by Revenue 2013
Exhibit 24: VCA: Business Segmentation by Revenue 2013
Exhibit 25: VCA: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 26: VCA: Geographical Segmentation by Revenue 2013
Exhibit 27: Mindray Medical International: Business Segmentation by Revenue 2013
Exhibit 28: Mindray Medical International: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 29: Mindray Medical International: Geographical Segmentation by Revenue 2013
Exhibit 30: Zoetis: Business Segmentation by Revenue 2013
Exhibit 31: Zoetis: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 32: Zoetis: Geographical Segmentation by Revenue 2013
